Purdue Pharma, Canada

Quick facts

Phase 3 pipeline

• PRC-063 oral capsules · Pain, Depression
  PRC-063 oral capsules are a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Purdue Pharma, Canada portfolio CI brief
• Purdue Pharma, Canada pipeline updates RSS